SCOT Study | Scleroderma: Cyclophosphamide or Transplantation
Links shared publicly online about this topic.
- 919total visits
SCOT Study | Scleroderma: Cyclophosphamide or Transplantation
SCOT (Scleroderma: Cyclophosphamide or Transplantation) is a clinical research study, designed for people with severe forms of scleroderma, that compares two investigational approaches.
View full resource at sclerodermatrial.org
Tags: Scleroderma, Transplantation
Most Recently Shared on August 26, 2010 at 2:57 pm By:
RT @NIAIDNews: People ages 18-69 with severe #scleroderma needed for NIAID #treatment #clinicaltrial http://j.mp/b82zYu
Advertisement
